Trade Summary

1 month ago, Gavel Steve, serving as CHIEF COMMERCIAL OFFICER at Cabaletta Bio, Inc. (CABA), purchased 22,170 shares at $2.27 per share, for a total transaction value of $50,215.00. Following this transaction, Gavel Steve now holds 22,170 shares of CABA.

The trade was executed on Wednesday, January 21, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, January 21, 2026, meaning the disclosure happened on the same day as the trade.

Cabaletta Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.